| http://www.w3.org/ns/prov#value | - Only patients whose tumors have at least one of these mutations will be eligible for the study. (This study also is enrolling patients with other types of cancers.)This is a Phase I-II trialwhat is involved:Participants will receive the following:AZD5363 by mouthDabrafenib (Tafinlar??) by mouthAdditional procedures:Please contact research siteTrial length:As long as benefit is shownPost-trial follo
|
